Therapeutic potential of puerarin against cerebral diseases: From bench to bedside.

The incidence of cerebral diseases is rapidly increasing worldwide, and they have become an important challenge for modern medicine. Most of the available chemical drugs used in the treatment of cerebral diseases are highly toxic and single-targeted. Therefore, novel drugs from natural resources have attracted much attention for their potential to manage cerebral diseases. Puerarin is a natural isoflavone isolated from the roots of Pueraria species such as P. lobata (Willd.) Ohwi, P. thomsonii, and P. mirifica. Several authors have reported the beneficial effects of puerarin in cerebral ischemic disease, intracerebral hemorrhage, vascular dementia, Alzheimer's disease, Parkinson's disease, depression, anxiety, and traumatic brain injury. This review summarizes the brain pharmacokinetics, brain drug delivery system, clinical use (in cerebral diseases), toxicity, and the adverse clinical reactions of puerarin. We have systematically presented the pharmacological actions and the molecular mechanisms of puerarin in various cerebral diseases to provide a direction for future researches on the therapeutic use of puerarin in cerebral diseases. Copyright © 2023. Published by Elsevier B.V.

Citation

Tian Liu, Kai Su, Weiye Cai, Hui Ao, Mingxiu Li. Therapeutic potential of puerarin against cerebral diseases: From bench to bedside. European journal of pharmacology. 2023 Aug 15;953:175695

Mesh Tags

Substances

PMID: 36977450

search → result